课题基金 / 基金详情

Minority Based Community Clinical Oncology Program

Minority Based Community Clinical Oncology Program
基于少数民族的社区临床肿瘤学计划
批准号:
7282269
负责人:
DAVID J PEACE
金额:
$70.5万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-08-15 至 2012-05-31

项目摘要

项目成果

DAVID J PEACE的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):保持非裔美国男性在硒和维生素E硒和维生素E癌症预防试验(SELECT)中的成功保留,以及非洲裔美国男性在SELECT辅助研究中的成功招募和保留。2. 通过采用行之有效的招募和保留策略,增加少数群体参与癌症治疗方案,为少数群体提供最先进的癌症治疗机会;通过与nci资助的两个主要项目[人口健康和健康差异中心(CPHHD)和患者导航员研究项目(PNRP)]和英格尔斯卫生系统合作,提高整个芝加哥和印第安纳州西北部地区的癌症预防和控制(CaP/C)水平。UIC MB-CCOP计划利用这些伙伴关系建立一个结构和框架,以克服招聘和保留障碍,并为整个地区的少数民族社区提供参与CaP/C试验的机会。4. 提高卫生保健提供者、社区领导人和地方组织对UIC MB-CCOP活动的认识、理解和参与。这些目标将通过在UIC血液学/肿瘤学部门建立的少数民族临床研究总部来实现,并利用几个研究基地:癌症和白血病B组(CALGB): 1996年以来的主要成员西南肿瘤组(SWOG): CCOP扩大准入试点计划(1998年)东部肿瘤合作组(ECOG): 2005年7月15日接受(经NCI许可)妇科肿瘤组(GOG)国家外科辅助乳房和肠项目(NSABP):STAR & P-4密歇根大学CCOP研究基地:CaP/C罗切斯特大学CCOP研究基地:CaP/C
英文摘要
DESCRIPTION (provided by applicant): 1. To maintain the successful retention of African-American men to the Selenium and Vitamin E Selenium and Vitamin E Cancer Prevention Trial (SELECT) and the successful recruitment and retention of African- American men to SELECT ancillary studies. 2. To provide access to state-of-the-art cancer treatment for minority individuals by increasing minority participation in cancer treatment protocols using proven recruitment and retention strategies: 3. To raise the level of cancer prevention and control (CaP/C) opportunities offered throughout the Chicago and Northwest Indiana region by partnering with two major NCI-funded programs [Center for Population Health and Health Disparities (CPHHD) and the Patient Navigator Research Program (PNRP)] and Ingalls Health System. The UIC MB-CCOP plans to leverage these partnerships to establish a structure and framework to overcome the barriers to recruitment and retention and provide access to CaP/C trials to minority communities in this entire region. 4. To increase the awareness, understanding, and involvement of health care providers, community leaders, and local organizations in UIC MB-CCOP activities. These aims will be achieved by an established minority clinical research headquarters within the UIC Section of Hematology/Oncology and utilizes several research bases: Cancer and Leukemia Group B (CALGB): Main Member since 1996 Southwest Oncology Group (SWOG): CCOP Expanded Access Pilot Program (1998) Eastern Cooperative Oncology Group (ECOG): Accepted July 15, 2005 (by NCI permission) Gynecologic Oncology Group (GOG) National Surgical Adjuvant Breast and Bowel Project (NSABP): STAR & P-4 The University of Michigan CCOP Research Base: CaP/C The University of Rochester CCOP Research Base: CaP/C
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Pilot Phase IB trial of PSA-Peptide Based Specific Active Immunotherapy
A PILOT PHASE IB TRIAL OF A PSA PEPTIDE VACCINE
A PILOT PHASE IB TRIAL OF A PSA PEPTIDE VACCINE
Minority Based Community Clinical Oncology Program
海外基金